Edition:
India

AzurRx BioPharma Inc (AZRX.OQ)

AZRX.OQ on NASDAQ Stock Exchange Capital Market

3.50USD
17 Jan 2018
Change (% chg)

$0.02 (+0.57%)
Prev Close
$3.48
Open
$3.40
Day's High
$3.68
Day's Low
$3.40
Volume
13,413
Avg. Vol
13,336
52-wk High
$5.25
52-wk Low
$2.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.279
Jun '17 0.00 -0.265
Mar '17 0.00 -0.292
FY 2016 Dec '16 0.00 -0.608
Sep '16 0.00 -0.530
Jun '16 0.00 -0.392
Mar '16 0.00 -0.207
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.17 -0.17 -0.17 --
Quarter Ending Jun-18 1 -0.16 -0.16 -0.16 --
Year Ending Dec-18 1 -0.79 -0.79 -0.79 -0.46
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.11 32.89
P/E High - Last 5 Yrs. -- 40.91 45.60
P/E Low - Last 5 Yrs. -- 23.78 24.32
Beta -- 0.90 0.89
Price to Sales (TTM) -- 3.94 5.41
Price to Book (MRQ) 8.59 4.82 5.38
Price to Tangible Book (MRQ) 36.95 5.53 6.76
Price to Cash Flow (TTM) -- 23.03 23.42
% Owned Institutions 5.56 1.12 1.81

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.69 43.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.57 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.67 5.40
Sales - 5 Yr. Growth Rate -- 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 32.20 16.27 19.39
EPS (TTM) vs TTM 1 Yr. Ago -42.53 -- --
EPS - 5 Yr. Growth Rate -- 9.87 10.80
Capital Spending - 5 Yr. Growth Rate -- 15.28 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 1.97 2.88 2.97
LT Debt to Equity (MRQ) 0.00 9.70 11.90
Total Debt to Equity (MRQ) 14.45 13.67 16.16
Interest Coverage (TTM) -2.14 36.31 33.26

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.22 54.87
Gross Margin - 5 Yr. Avg. -- 52.38 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.52 15.31
Operating Margin (TTM) -- 14.55 7.77
Operating Margin - 5 Yr. Avg. -- 14.46 10.80
Pre-Tax Margin (TTM) -- 14.99 8.57
Pre-Tax Margin - 5 Yr. Avg. -- 14.78 11.21
Net Profit Margin (TTM) -- 11.26 4.88
Net Profit Margin - 5 Yr. Avg. -- 11.11 7.51
Effective Tax Rate (TTM) -- 23.19 23.08
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 950,005,605 859,855,848
Net Income/Employee (TTM) -- 111,774,344 101,151,536
Receivable Turnover (TTM) -- 5.61 5.76
Inventory Turnover (TTM) -- 2.57 3.33
Asset Turnover (TTM) 0.00 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -186.57 11.41 10.99
Return on Assets - 5 Yr. Avg. -- 12.99 12.42
Return on Investment (TTM) -- 14.85 14.44
Return on Investment - 5 Yr. Avg. -- 16.99 16.26
Return on Equity (TTM) -- 16.31 16.10
Return on Equity - 5 Yr. Avg. -- 18.05 17.54
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -264.31 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AzurRx BioPharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.09%
# of Holders: 18
Total Shares Held: 935,084
3 Mo. Net Change: -123
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.